Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies

INTRODUCTION: Beta-blockers are widely prescribed to manage hypertension and cardiovascular diseases and have been suggested as an attractive therapy to improve the prognosis of sepsis. Herein, we investigated the potential benefits of premorbid selective beta-blocker use in sepsis with a real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Shiao-Ya, Lai, Chih-Cheng, Teng, Nai-Chi, Chen, Chao-Hsien, Hsu, Chun-Chun, Chan, Nai-Ju, Wang, Cheng-Yi, Wang, Ya-Hui, Lin, You Shuei, Chen, Likwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151496/
https://www.ncbi.nlm.nih.gov/pubmed/37144032
http://dx.doi.org/10.3389/fmed.2023.1105894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151496/
https://www.ncbi.nlm.nih.gov/pubmed/37144032
http://dx.doi.org/10.3389/fmed.2023.1105894

Ejemplares similares